| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | Jan 12, 2024 | Vera Therapeutics, Inc. | 10% Owner | Sell | 15.0 | -1,050,000 | -19.27% | ✗ | $18.9M |
| Aug 7, 2023 | Aug 9, 2023 | Vistagen Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +775,756 | 97.06% | ✗ | $18M |
| Jun 20, 2023 | Jun 22, 2023 | Vera Therapeutics, Inc. | 10% Owner | Buy | 96.3 | +448,217 | 8.96% | ✗ | $6.8M |
| Feb 23, 2023 | Feb 27, 2023 | Enliven Therapeutics, Inc. | 10% Owner | Buy | 91.3 | +730,512 | 101.72% | ✗ | $13.7K |
| Feb 21, 2023 | Feb 23, 2023 | Enliven Therapeutics, Inc. | 10% Owner | Buy | 82.5 | +31,759 | 1.12% | ✗ | $163.5K |